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Objective: To analyze the magnetic resonance (MR) imaging findings of invasive micropapillary carcinoma of the breast.
Materials and Methods: MR images were retrospectively evaluated in 14 patients (age range: 37-67, mean age: 49 years) 
with pathologically confirmed invasive micropapillary carcinoma of the breast. The enhancement type (mass/non-mass), 
shape, margin, contrast enhancement, and time-intensity curve pattern on the dynamic study were correlated with the 
histopathologic features. Associated findings, such as edema, nipple change, skin change and enlarged axillary lymph nodes 
were also studied.
Results: The most common features of the masses were irregular shape (12 of 14 patients, 85.8%) and irregular or 
spiculated margin (11 of 14 patients, 78.7%). The contrast enhancement was heterogeneous in 11 patients (78.7%), rim 
enhancement in 2 cases (14.2%), and homogeneous in one patient (7.1%). The predominant kinetic pattern was rapid 
increase (14 of 14, 100%) in the initial phase and washout (11 of 14, 78.7%) in the delayed phase. Associated non-mass 
like enhancement was shown in 4 patients, representing ductal carcinoma in situ. MR imaging helped detect additional 
sites of cancer other than the index lesion in 3 patients (21.4%). Enlarged axillary lymphadenopathy was identified in 7 of 
the 14 patients (50%).
Conclusion: Invasive micropapillary carcinoma appears as a mass with an irregular shape, irregular or spiculated margin 
and heterogeneous enhancement on MR imaging. Though these findings are not specific and are also observed with other 
breast malignancies, invasive micropapillary carcinoma frequently showed multiple lesions, accompanying non-mass 
enhancement and axillary lymph node enlargement. 
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INTRODUCTION
Invasive micropapillary carcinoma is a rare type of 
invasive ductal carcinoma of the breast, accounting for 
1.7-4% of breast cancers (1-4). Compared with ductal 
carcinoma, micropapillary carcinoma shows more distinctive 
architecture characterized by tufts of cells arranged in 
pseudopapillary structures devoid of fibrovascular cores 
and surrounded by empty, clear spaces lined by delicate 
strands of fibrocollagenous stroma (1). Although invasive 
micropapillary carcinoma is rare, it has clinical significance 
due to high frequency of lymphovascular invasion and 
axillary nodal metastasis, a greater degree of logo-regional 
recurrence and a poor prognosis (1, 3, 5). However, there is 
scant information about the radiologic features of invasive 
micropapillary carcinoma of the breast and most cases are 
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described by their mammographic and sonographic features 
only. Magnetic resonance (MR) imaging examination of 
invasive micropapillary carcinoma of the breast is limited 
in the literature. Frequently, most cases of invasive 
micropapillary carcinoma exhibit a heterogeneous pattern 
of micropapillary forms mixed with the common forms of 
invasive ductal cancer (3). In this study, we included only 
the genuine type of invasive micropapillary carcinoma to 
better describe the radiologic features. The purpose of this 
study was to describe the MR imaging findings of genuine 
invasive micropapillary carcinoma of the breast and to 
correlate them with histopathologic features.
MATERIALS AND METHODS
The pathologic reports of patients with breast carcinoma 
at our institution between January 2007 and January 2011 
were reviewed, and 21 cases of patients with pure invasive 
micropapillary carcinoma of the breast were found. Genuine 
invasive micropapillary carcinoma was defined as more than 
90% of the tumor showing a micropapillary pattern. We 
excluded 6 patients who had not undergone preoperative MR 
imaging and one patient who had undergone pre-operative 
neoadjuvant chemotherapy. Consequently, 14 patients were 
included in this study. Eleven patients presented with a 
palpable breast mass and three patients were detected by 
a screening exam. MR imaging was performed to evaluate 
the tumor extent after diagnosis of breast cancer by 
sonographically guided 14-gauge automated core needle 
biopsy in all of the patients. All patients were women with 
the mean age of 49 years (range, 37-67 years). Of this, 
10 patients underwent breast conservation surgery and 4 
patients underwent mastectomy. The time interval between 
the breast MR imaging and surgical resection was 1-17 days 
(mean: 6 days). The institutional review board approved 
this retrospective study and did not require informed 
patient consent for review of their images and records.
Standard two-view mammography was performed using 
a Senographe 2000 D system (GE Healthcare, Milwaukee, 
WI, USA). Complementary views such as spot compression 
magnification views were obtained when necessary. Each 
mammographic lesion was reviewed according to the 
lesion type (mass only, mass with microcalcifications, 
microcalcifications only, focal asymmetry, architectural 
distortion), mass characteristics (shape and margin), 
distribution and morphology of microcalcifications using 
the criteria given by the American College of Radiology’s 
Breast Imaging Reporting and Data System (BI-RADS) (6). 
mammography was available for review for 12 patients 
whereas sonographic results were available for review in 
all patients. Each sonographic lesion was reviewed for 
characteristics of the mass (shape, margin, echo pattern, 
posterior acoustic features) and presence of calcifications, 
using the criteria given by the American College of 
Radiology’s BI-RADS (7). 
MR Imaging Technique
Breast MR imaging was performed in prone position using 
a dedicated surface breast coil with a 1.5-T (Signa Twin 
Speed Excite 1.5 T, GE Medical Systems, Milwaukee, WI, USA) 
and 3.0-T systems (Tim Trio, Siemens, Erlangen, Germany) 
in 5 and 9 patients respectively and included axillary lymph 
nodes from the level of the suprasternal notch line down. 
MR imaging consisted of a fat-suppressed, T1-weighted, T2-
weighted fast spin echo, and gadolinium-enhanced images. 
MR imaging was performed with a 1.5-T MR scanner in 5 
patients with the following parameters: axial fat-saturated 
T2-weighted spin echo images of bilateral whole breast (TR/
TE, 4016.7/88.4; echo train length, 12; section thickness, 
4 mm; field of view, 280 x 280 mm; matrix size, 288 x 256; 
gap, 1 mm; acquisition, 1) and sagittal fat-saturated T1-
weighted images of bilateral whole breast (TR/TE, 700/9; 
echo train length, 0; section thickness, 4 mm; field of 
view, 180 x 180 mm; matrix size, 256 x 192; gap, 1 mm; 
acquisition, 1). After the initial examination, dynamic 
contrast-enhanced images were obtained by sagittal fat 
saturated T1-weighted spoiled gradient echo images with 
subtraction (3D-FLASH, TR/TE, 6.5/3.1; echo train length, 0; 
flip angle, 0; section thickness, 2.5 mm; field of view, 200 x 
200 mm; matrix size, 256 x 256; no gap; acquisition, 1).
MR imaging was performed with a 3-T MR scanner in 9 
patients with the following parameters: axial fat-saturated 
T2-weighted spin echo images of bilateral whole breast (TR/
TE, 5200/79; echo train length, 21; section thickness, 4 
mm; field of view, 320 x 320 mm; matrix size, 384 x 288; 
gap, 4.8 mm; acquisition, 1) and sagittal fat-saturated T1-
weighted images of bilateral whole breast (TR/TE, 500/12; 
echo train length, 3; section thickness, 4 mm; field of 
view, 180 x 180 mm; matrix size, 320 x 224; gap, 1 mm; 
acquisition, 1). After the initial examination, dynamic 
contrast-enhanced images were obtained using axial fat 
saturated T1-weighted spoiled gradient echo images (TR/
TE, 4.3/1.6; echo train length, 1; flip angle, 10; section 
thickness, 2 mm; field of view, 320 x 320 mm; matrix 
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size, 448 x 246; gap, 1 mm acquisition, 1). For dynamic 
contrast-enhanced images, a bolus injection of 0.1 mmol/
kg of gadopentetate dimeglumine (Magnevist, Schering 
Berlin, Germany) was administered into the antecubital vein 
within 7-10 s, followed by a 16 mL saline flush. MR dynamic 
images, once before and five times after administration of 
contrast material, were obtained in bilateral whole breast at 
40 s intervals. 
After examination, standard subtraction images (un-
enhanced images were subtracted from the early post-
contrast images) and reverse subtraction images (last 
post-contrast images were subtracted from the early 
post-contrast images) were obtained on a pixel-by-pixel 
basis. The reformatted images with a maximum intensity 
projection were then created from the standard and reverse 
subtraction images. For enhancement kinetics analysis, 
time-intensity curves were plotted from the signal intensity 
values obtained in the regions of interest on serial dynamic 
images. To assess the early phase signal intensity increase, 
we evaluated the enhancement for the first post-contrast 
image at 60 s after injection of the contrast material. 
Interpretation of the MR Imaging Findings
The breast lesions were analyzed using the BI-RADS 
MR lexicon (8). Areas of abnormal enhancement were 
described as mass or non-mass like enhancement. For 
the evaluation of the masses, MR images were reviewed 
for the evaluation of size, shape (round/oval, lobular, or 
irregular), margin (smooth, irregular, or spiculated), and 
contrast enhancement within the mass (homogeneous, 
heterogeneous, rim, central, enhancing internal septations, 
or dark internal septations), and the signal intensity. 
Shape and margin analysis was performed on the first post-
contrast image. For non-mass like enhancements, MR images 
were reviewed for the evaluation of distribution (focal 
area, linear, ductal, segmental, regional, multiple regions, 
or diffuse) and internal enhancement (homogeneous, 
heterogeneous, clumped, stippled, or reticular/dendritic). 
The type of time-intensity curve was evaluated. The initial 
enhancement phase of the kinetic curve (slow, medium, or 
rapid) and the delayed phase of the kinetic curve (persistent, 
plateau, or washout) were also evaluated. 
As defined by Liberman et al. (9), MR lesions were 
considered to be additional sites if they were located in a 
different breast quadrant than the index cancer, if they were 
in the same quadrant but were separated from the index 
cancer by at least 1.0 cm of intervening normal appearing 
tissue on MR imaging, or if they were in the same quadrant 
and contiguous with the index cancer but extended at least 
4.0 cm beyond the site of the index cancer.
Associated findings, such as edema, nipple change, 
skin change, and enlarged axillary lymph nodes, were 
also noted. Axillary lymph nodes that exhibited irregular 
contour, marked gadolinium enhancement and round hila 
and abnormal cortex were considered abnormal lymph nodes 
representing metastasis according to previously reported 
results. The sensitivity, specificity, positive predictive 
value, negative predictive value, and overall accuracy of MR 
imaging of axillary lymph node metastasis were calculated 
as sensitivity, TP / (TP + FN); specificity, TN / (TN + FP); 
positive predictive value, TP / (TP + FP); negative predictive 
value, TN / (TN + FN);and accuracy, (TP + TN) / (TP + FP 
+ FN + TN), where TP is the true-positive, TN the true-
negative, FP the false positive and FN the false-negative.
Histopathology
A text search for invasive micropapillary was performed 
in the institutional pathologic database. All pathologic 
specimens were reviewed by a breast pathologist with 
17 years of experience. In the present study, 10 patients 
underwent breast conserving surgery and 4 patients 
underwent modified radical mastectomy. The pathologist 
examined H and E-stained microscopic sections of the 
surgical specimen and interpreted the histopathologic 
findings are blinded of the MR imaging findings. Cases 
of tumor showing only small component of invasive 
micropapillary carcinoma were excluded and cases of tumor 
with more than 90% of the tumor showing a micropapillary 
pattern were included. The presence of associated ductal 
carcinoma in situ (DCIS), lympho-vascular invasion, and 
axillary lymph node status were evaluated. The MR imaging 
features were correlated with the histopathological findings 
by a single radiologist and a pathologist.
RESULTS
The age of 14 patients ranged between 37 and 67 years 
(mean age, 49 years). Physical examination revealed 
palpable, non-tender mass in 11 patients. Mammography 
was carried out in 12 patients in our institute and in two 
patients had the mammography at an outside institution 
and which were not available for review. Mammographic 
parenchyma as per the Breast Imaging Reporting and Data 
System lexicon was heterogeneously dense in six (50%) 
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patients, showing scattered fibroglandular densities in 
four (33.3%), and consisted of almost entirely fat in two 
(16.7%). 
The mammographic findings of 12 patients consisted mass 
in 5 patients (41.7%) and mass with microcalcifications in 
7 patients (58.3%) (Fig. 1). Multiple masses were detected 
in two patients. The mean diameter of these masses was 
1.7 cm (range, 1.2-2.9 cm). The masses of 10 patients 
were irregular (83.3%) and two were oval (16.7%). The 
margins of the masses were spiculated in 6 (50%), ill-
defined in 5 patients (41.7%) and microlobulated in one 
patient (8.3%). Microcalcifications were present in 7 
patients and these microcalcifications were outside of the 




Fig. 1. Forty six-year-old woman with palpable mass in upper outer quadrant of right breast.
A. Mediolateral oblique mammogram shows irregular mass (arrow) and segmental distributed pleomorphic microcalcifications (arrowheads) 
outside of mass, extending anterior to mass. B. Early phase of dynamic enhancement MR imaging shows irregular, heterogeneously enhancing 
mass (arrow) with adjacent multiple regions of clumped enhancement (arrowheads) extending less than 4.0 cm, representing pathologically 
proven ductal carcinoma in situ. C. Photomicrograph of histopathological specimen (original magnification, x 100; hematoxylin-eosin stain) of 
tumor showed small cell clusters surrounded by empty spaces lined by delicate strands of stroma.
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were fine pleomorphic and amorphous in 5 patients (71.4%) 
and 2 (28.6%) patients respectively. The distribution was 
segmental in 4 (57.1%), regional in 2 (28.6%) and clustered 
in 1 (14.3%) patient. Suspicious axillary lymphadenopathy 
was identified with mammography in 1 of the 12 patients.
Sonography was performed in all the patients including 
sonographically guided percutaneous 14-gauge core 
needle biopsy. In sonographic analysis, all cases showed 
irregular hypoechoic masses with a not-circumscribed 
margin. Multiple irregular hypoechoic masses were seen in 
4 patients. In 2 patients, additional irregular hypoechoic 
masses were also detected on sonography that were 
clinically and mammographically occult. In 5 patients, 
calcifications were seen as bright punctuate echoes within 
an irregular and indistinct hypoechoic mass. MR imaging 
was performed to evaluate the tumor extent after the 
diagnosis of the breast cancer. 
MR imaging was useful in detecting all 14 invasive 
micropapillary carcinomas which are summarized in Table 
1. The most common features of the masses were irregular 
shape (12 of 14, 85.8%) and irregular or spiculated 
margin (11 of 14, 78.7%) (Fig. 1). Contrast enhancement 
within the mass was heterogeneous in 11 (78.7%) and 
rim enhancement in 2 (14.2%) patients. The predominant 
kinetic pattern was rapid increase (14 of 14, 100%) in 
the initial phase and washout (11 of 14, 78.7%) in the 
delayed phase. Associated non-mass like enhancement was 
shown in 4 patients (Fig. 1). In 3 patients, segmental or 
regional distributed microcalcifications on mammography 
were seen as non-mass like enhancement on MR imaging. 
The enhancement pattern of non-mass like enhancement 
was segmental clumped enhancement, multiple regional 
clumped, regional stippled and focal clumped enhancement 
were seen one patient each, representing the presence of 
accompanying DCIS. Additional sites of cancers other than 
the index lesion were detected in 3 patients (21.4%) (Fig. 
2). Two lesions were in the same quadrant and one was 
in a different quadrant. Targeted sonography revealed a 
sonographic correlate in two patients and sonographically 
guided localization was performed. Mastectomy was needed 
for one patient. Suspicious axillary lymphadenopathy was 
identified with MR imaging in 7 of the 14 patients (50%). 
Breast conserving surgery was performed in 10 patients 
and 4 patients underwent modified radical mastectomy. 
Axillary lymph node dissection was performed in 11 of 14 
patients and sentinel lymph node biopsy was performed 
in 3 patients. Breast cancer stage was stage I in 2 
(14.3%), stage II in 7 (50%) and stage III in 5. Based 
on histopathologic examination, we included the cases 
with more than 90% of the tumor consisting of invasive 
micropapillary pattern. Associated DCIS was found in 11 of 
the 14 patients (78.6%), usually mixed histologic type with 
cribriform, solid, and micropapillary patterns. One patient 
had bilateral breast cancer, and invasive ductal carcinoma, 
not otherwise specified, was diagnosed in the contra-lateral 
breast. Lympho-vascular invasion was found in 9 of the 
14 patients (64.3%). Axillary lymph node metastases were 
found in 10 of the 14 patients (71.4%). The sensitivity, 
specificity, positive predictive value, negative predictive 
value, and overall accuracy of MR imaging of axillary lymph 
node metastasis were 60, 75, 85.7, 42.9, and 64.3%, 
respectively. 
Follow-up data were available for 14 patients (12-42 
months). Hepatic metastases was detected in one patient 
at 34 months after the initial diagnosis. Locoregional 
recurrence in mastectomy site with hepatic and lung 
metastases was detected in one patient at 20 months after 
the initial diagnosis.
DISCUSSION
Invasive micropapillary carcinoma of the breast is a 
distinct histologic type of invasive carcinoma, that was first 











Smooth  3 (21.3)
Irregular  5 (36.1)




Rim enhancement  2 (14.2)
Central enhancement 0
Associated non-mass  
  like enhancement
Segmental clumped 1 (7.1)
Multiple regional clumped 1 (7.1)
Regional stippled 1 (7.1)
Focal clumped 1 (7.1)
Kinetic curve
  (delayed phase)
Persistent  2 (14.2)
Plateau 1 (7.1)
Washout 11 (78.7)
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described by Siriaunkgul and Tavassoli (10), characterized 
by a distinctive growth pattern of small, tightly cohesive 
cell clusters disposed within spaces resembling lymphatic 
vessels. Immunohistochemically, invasive micropapillary 
carcinoma exhibits the ‘inside-out’ pattern of epithelial 
membrane antigen expression (1). However, often most 
invasive micropapillary carcinomas show a heterogeneous 
pattern of invasive micropapillary pattern with a common 
type of invasive cancer (3). If the invasive micropapillary 
pattern was found throughout the lesion, the term genuine 
invasive micropapillary carcinoma is used and if the pattern 
was found as part of an otherwise conventional invasive 
ductal carcinoma, mixed invasive micropapillary carcinoma 
is used. If more than 90% of the tumor consisted of a 
micropapillary pattern, that tumor was classified as genuine 
invasive micropapillary carcinoma and included in this 
study.
To our knowledge, there is a limited amount of published 
information on the radiologic findings of pure invasive 
micropapillary carcinoma of the breast (11, 12). Günhan-
Bilgen et al. (11) reported the mammographic and 
sonographic findings of 16 pure invasive micropapillary 
carcinomas with spiculated, irregular or round, high density 
mass with or without associated microcalcifications. 
Sonography examinations revealed homogeneously 
hypoechoic, irregular or microlobulated mass with posterior 
acoustic shadowing or normal sound transmission. A study 
by Adrada et al. (12) suggested that the lesion was a high-
density irregular mass associated with microcalcifications 
on mammogram and a solid irregular hypoechoic mass with 
indistinct margins and frequent axillary nodal involvement 
on sonogram. Microcalcifications were representative of an 
associated DCIS component. The imaging characteristics 
were highly suggestive of malignancy in both studies.
However, few studies on the MR imaging findings of 
invasive micropapillary carcinoma of the breast exist; 
however, the number of patients in these studies was 
also small. Adrada et al. (12) reported the MR imaging 
findings of invasive micropapillary carcinoma of the breast 
in 5 lesions; four enhancing masses were present in three 
patients and non-mass like enhancement was found in 
two patients. The masses showed an irregular shape and 
spiculated margins. Similarly, Kubota et al. (13) reported the 
MR imaging findings of 8 breast carcinomas with a variable 
proportion of invasive micropapillary carcinoma. They 
compared the radiological imaging features of 8 invasive 
micropapillary carcinomas and 22 other types of invasive 
ductal carcinomas. There was no predictive descriptor in 
the BI-RADS lexicon for invasive micropapillary carcinoma 
on mammography and sonography. They found that 
invasive micropapillary carcinoma showed a characteristic 
irregular shaped mass on MR imaging more frequently 
A B
Fig. 2. Thirty nine-year-old woman with palpable mass in left breast.
A. Mediolateral oblique mammogram shows irregular equal density mass in left breast corresponding to area of palpation (arrows). B. Dynamic 
enhancement MR imaging shows irregular heterogeneously enhancing mass (arrows) with segmental clumped enhancement (arrowheads) 
extending 4 cm anterior to known invasive cancer. MR imaging found additional site. Mastectomy revealed invasive micropapillary carcinoma with 
extensive ductal carcinoma in situ.
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than other types of invasive ductal carcinomas. In a case 
report, MR imaging findings indicated breast cancer with 
an extensive intraductal component (14). In the present 
study, we included only genuineinvasive micropapillary 
carcinoma patients with most predominant features of the 
masses were irregular shape (12 of 14, 85.8%), irregular 
or spiculated margin (11 of 14, 78.7%) and heterogeneous 
contrast enhancement (78.7%). The MR imaging findings of 
invasive micropapillary carcinoma were highly suggestive of 
malignancy. In addition to the mass, associated non-mass 
like enhancement was detected in 4 patients and this was 
pathologically proven to be accompanying DCIS. 
Although MR imaging findings of invasive micropapillary 
carcinoma are not specific and may be seen with other 
breast malignancies, MR imaging detected additional sites 
in 3 of 14 patients (21.4%) and defined the tumor extent 
more accurately than mammography. In one patient, 
an additional mass that was detected in a different 
breast quadrant than the index cancer was not seen on 
mammography, and this was pathologically proven to be 
DCIS. In one patient, an additional enhancing mass was 
detected in the same quadrant however, it was separated 
from the index cancer by 1.5 cm of intervening normal 
appearing tissue on MR imaging. In one patient, segmental 
clumped enhancement was present and contiguous with 
the index cancer but extended 4.0 cm beyond the site 
of the index cancer, suggesting the presence of DCIS. 
Subsequently, due to the MR imaging findings, a change in 
management was made. Invasive micropapillary carcinoma 
frequently showed multiplicity. Walsh and Bleiweiss (15) 
reported invasive micropapillary carcinoma was multifocal 
in 25 of 80 cases (31.4%). 
Accompanying DCIS was found in 11 of the 14 patients 
(78.6%) as it was usually of mixed histologic type with 
cribriform, solid, and micropapillary patterns. The most 
frequent intraductal component was of the micropapillary 
type in the study by Walsh and Bleiweiss (15) but typically 
had intermediate to high-grade nuclei and necrosis. 
Adrada et al. (12) reported that 26 of 28 patients (93%) 
had an intraductal component, usually of mixed type with 
cribriform, solid, and micropapillary patterns. 
Invasive micropapillary carcinoma has a high frequency 
of axillary lymph node metastasis, with reports of 66.6-
90.5% (3, 16, 17). Walsh and Bleiweiss (15) reported that 
small micropapillary carcinomas seem to show the same 
proclivity for lymphatic spread and nodal dissemination as 
larger micropapillary carcinomas despite their minute size, 
and invasive micropapillary carcinomas less than 5 mm in 
size exhibited lymph node metastasis at a rate of 75%. 
As suggested by previous studies, it is not the tumor size 
or the amount of the invasive micropapillary carcinoma 
component in the tumor, but the histologic features and 
stromal reactions that correlate with the aggressiveness of 
the tumor (18). It has been proposed that the histologic 
grade, lymphatic vessel density, and lymphocyte infiltration 
of invasive micropapillary carcinoma may be the key factors 
that influence lymph node metastasis (18). In this study, 
lympho-vascular invasion was found in 9 of 14 patients 
(64.3%) and axillary lymph node metastases were found 
in 10 of 14 patients (71.4%). The diagnosis of axillary 
lymph node metastasis, the sensitivity, specificity, positive 
predictive value, negative predictive value, and overall 
accuracy of MR imaging were 60, 75, 85.7, 42.9, and 
64.3%, respectively. This result suggests that patients with 
invasive micropapillary carcinoma have a high possibility of 
axillary lymph node metastases regardless of the radiologic 
findings and require pathologic examination of the axillary 
lymph nodes. 
In conclusion, invasive micropapillary carcinoma was 
presented as a mass with an irregular shape, irregular or 
spiculated margin and heterogeneous enhancement and 
frequently showed multiple lesions, accompanying non-
mass enhancement and axillary lymph node enlargement. 
The present study suggest that, MR imaging may be 
an important diagnostic tool for defining the extent of 
the tumor and excluding the possibility of multiplicity, 
which would not be apparent through mammography or 
sonography.
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